教室紹介

2002年業績集

  1. Arisawa C, Kageyama Y, Kawakami S, Kihara K.TNP-470 combined with nicardipine suppresses in vivo growth of PC-3, a human prostate cancer cell line.Urol Oncol,7:229-234, 2002

  2. Fujii Y, Okada Y, Moore JP, Dalkin AC, Winters SJ.Evidence that PACAP and GnRH down-regulate follicle-stimulating hormone-mRNA levels by stimulating follistatin gene expression: effects on folliculostellate cells, gonadotrophs and LbT2 gonadotroph cells.Mol Cell Endocrinol,192:55-64, 2002

  3. Hayashi T, Kageyama Y, Ishizaka K, Kihara K, Oshima H.Involvement of apoptosis in the control of Sertoli and pre-meiotic germ cell numbers in the developing rabbit testis.Andrologia,34:34-40, 2002

  4. Ichiyanagi N, Tsujii T, Masuda H, Kihara K, Goto M, Azuma H.Changed Responsiveness of the detrusor in rabbits with alloxan induced hyperglycemia: Possible role of 5-Hydroxytryptamine for diabetic bladder dysfunction.J Urol,168:303-307, 2002

  5. Ishimaru H, Kageyama Y, Hayashi T, Nemoto T, Eishi Y, Kihara K.Expression of matrix metalloproteinase-9 and bombesin/gastrin releasing peptide in human prostate cancers and their lymphnodes metastasis.Acta Oncol,41: 289-296, 2002

  6. Ishizaka K, Suzuki M, Kageyama Y, Kihara K, Yoshida K.Bone mineral density in hypogonadal men remains low after long-term testosterone replacement.Asian J Androl,4:117-21, 2002

  7. Kageyama Y, Ishizaka K, Iwashina M, Sasano H, Kihara K.A case of ACTH-independent bilateral macronodular adrenal hyperplasia successfully treated by subtotal resection of the adrenal glands: Four-year follow-up.Endocrine J,49:227-229, 2002

  8. Kageyama Y, Kihara K, Ishizaka K, Okuno T, Hayashi T, Kawakami S, Masuda H, Suzuki M, Hyochi N, Arai G.Endoscopic minilaparotomy radical nephrectomy for chronic dialysis patients.Int J Urol.9:73-76, 2002

  9. Kageyama Y, Sakai Y, Arai G, Hyouchi N, Suzuki M, Masuda H, Kawakami S, Hayashi T, Okuno T, Kobayashi T, Kihara K.Intracavitary administraion of OK-432 with subcutaneous priming for malignant ascites in a case of advanced renal cell carcinoma.Int J Urol.9:57-59, 2002

  10. Kageyama Y, Kihara K, Ishizaka K, Okuno T, Kawakami S, Fujii Y, Masuda H,Suzuki M, Hyouchi N, Arai G, Saito K and Sakai Y.Endoscopicope-assisted minilaparotomy (endoscopic minilaparotomy) for retroperitoneal Schwannoma:Experience with three cases.Jpn J Clin Oncol.32: 177-180, 2002

  11. Kageyama Y, Kihra K, Yokoyama M, Sakai Y, Koga F, Saito K, Yano M, Arai G,Hyochi N, Masuda H, Fujii Y, Kawakami S and Kobayashi T.Endoscopic minilaparotomy partial nephrectomy for solitary renal cell carcinoma smallerthan 4 cm.Jpn J Clin Oncol32:417-421, 2002

  12. Kawakami S, Arai G, Hayashi T, Fujii Y, Xia G, Kageyama Y, Kihara K.PPARg ligands suppress proliferation of human urothelial basal cells in vitro.J Cell Physiol,191:310-319, 2002

  13. Kawakami S, Fujii Y, Okada Y, Winters SJ.Paracrine regulation of FSH by follistatin in folliculostellate cell-enriched primate pituitary cell cultures.Endocrinology,143:2250-8, 2002

  14. Li G, Kawakami S, Kageyama Y, Chunyin Y, Saito K, Kihara K.IFNg-induced up-regulation of PD-ECGF/TP enhances the cytotoxicity of 5-fluorouracil and 5ﾕ-deoxy-5-fluorouridine in human bladder cancer cells.Anticancer Res,22:2607-2612, 2002

  15. Masuda H, Okuno T, Suzuki M, Kihara K, Goto M and Azuma H.Different distribution of nitric oxide synthase and soluble guanylyl cyclase activities between detrusor and proximal urethra of the rabbit.J Urol,168: 2286-2290, 2002

  16. Masuda H, Tsujii T, Okuno T, Kihara K, Goto M, Azuma H.Accumulated endogenous NOS inhibitors, decreased NOS activity, and impaired cavernosal relaxation with ischemia.Am J Physiol Regul Integr Comp Physiol,282:R1730-1738, 2002

  17. Masuda H, Tsujii T, Okuno T, Kihara K, Goto M, Azuma H.Localization and role of nitric oxide synthase and endogenous nitric oxide synthase inhibitors in the rabbit lower urinary tract.J Urol,167:2235-40, 2002

  18. Matsuoka Y, Machida T, Oka K, Ishizaka K.Clear cell adenocarcinoma of the urinary bladder inducing acute renal failure.Int J Urol.9:467-469, 2002

  19. Okada Y, Osada M, Kurata S, Sato S, Aisaki K, Kageyama Y, Kihara K,Ikawa Y, Katoh I.p53 Gene family p51 (p63)-encoded, secondary transactivator p51B (TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.Exp Cell Res,276:194-200, 2002

  20. Saito K, Fujii Y, Kasahara I, Kobayashi N, Kasuga T, and Kihara K.Malignant clear cell sugar tumor of the kidney: Clear cell variant of epithelioid angiomyolipoma.J Urol,168:2533-2534, 2002

  21. Xia G, Kageyama Y, Hayashi T, Hyochi N, Kawakami S, Kihara K.Positive expression of HIF-2a/EPAS1 in invasive bladder cancer.Urology,59:774-778, 2002

  22. 林　哲夫，酒井康之，齋藤一隆，新井　学，兵地信彦，鈴木理仁，増田　均，川上　理，奥野哲男，小林　剛，影山幸雄，木原和徳.前立腺肥大症に対するナフトピジルと塩酸タムスロシンの臨床効果の比較検討.泌尿紀要48:7-11, 2002

  23. 石坂和博、木原和徳：性分化.ウロナーシング7：65-70, 2002

  24. 木原和徳,影山幸雄、小林剛ほか.ミニマム創内視鏡下ストマ創利用 膀胱全摘＋回腸導管造設.Video Journal of JUA;（泌尿器科学会誌　 94: No4,2003.）9(2):2003

  25. 木原和徳.性機能障害：射精障害.排尿障害プラクティス，10:50-55, 2002

  26. 木原和徳.男性性機能不全-ED関連の基礎・臨床関連の進歩-：射精のメカニズム.日本臨床60：83-87、2002

  27. 木原和徳：射精障害の自律神経機序；自律神経損傷と再建 自律神経39：139-141、2002

  28. 木原和徳、影山幸雄、小林剛、奥野哲男、川上　理、林　哲夫、増田　均、鈴木理仁、兵地信彦、新井　学、石坂和博.ミニマム創・内視鏡下泌尿器手術　木原和徳 編著.医学書院2002

  29. 木原和徳.臨床研修実践マニュアル　腎癌、膀胱癌　奈良信雄編.南江堂2002

  30. 木原和徳.神経損傷による射精障害。アジアの性科学研究 島崎継雄編.東京フリープレス社pp125-127 2002

  31. 増田　均、東　洋.NOの病態生理ー創薬への展開ー；内因性NOS阻害物質と疾病.日薬会誌119:29-35, 2002

  32. 増田　均、木原和.尿路性器系疾患. 勃起障害(ED). 本邦臨床統計集３；日本臨床社60:585-592, 2002

  33. 増田　均、木原和徳.インポテンス.腎疾患最新の治療2002-2004 南江堂

  34. 増田　均.ハイテク泌尿器科治療最前線:膀胱腫瘍再発予防に効果を発揮-.月刊新医療335:102-103, 2002

  35. 松岡　陽，石阪和博，町田竜也，小林　剛，岡　薫.ピエゾ型砕石装置ESL-500Aを用いた上部尿路結石2019症例の検討.日泌尿会誌,93(3):476-82, 2002